These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15863303)
1. EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828. Binderup E; Björkling F; Hjarnaa PV; Latini S; Baltzer B; Carlsen M; Binderup L Bioorg Med Chem Lett; 2005 May; 15(10):2491-4. PubMed ID: 15863303 [TBL] [Abstract][Full Text] [Related]
2. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties. Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551 [TBL] [Abstract][Full Text] [Related]
3. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs. Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604 [TBL] [Abstract][Full Text] [Related]
4. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy. Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162 [TBL] [Abstract][Full Text] [Related]
5. Water-soluble prodrugs of an Aurora kinase inhibitor. Oslob JD; Heumann SA; Yu CH; Allen DA; Baskaran S; Bui M; Delarosa E; Fung AD; Hashash A; Hau J; Ivy S; Jacobs JW; Lew W; Maung J; McDowell RS; Ritchie S; Romanowski MJ; Silverman JA; Yang W; Zhong M; Fuchs-Knotts T Bioorg Med Chem Lett; 2009 Mar; 19(5):1409-12. PubMed ID: 19186057 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate. Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315 [TBL] [Abstract][Full Text] [Related]
7. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs. Pettit GR; Thornhill A; Melody N; Knight JC J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system. Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002 [TBL] [Abstract][Full Text] [Related]
10. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines. Jain M; Fan J; Baturay NZ; Kwon CH J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662 [TBL] [Abstract][Full Text] [Related]
11. Do prodrugs deliver? Smith DA Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853 [TBL] [Abstract][Full Text] [Related]
12. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor. Suzuki T; Hisakawa S; Itoh Y; Maruyama S; Kurotaki M; Nakagawa H; Miyata N Bioorg Med Chem Lett; 2007 Mar; 17(6):1558-61. PubMed ID: 17257837 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue. Wang Y; Li L; Tian Z; Jiang W; Larrick JW Bioorg Med Chem; 2006 Dec; 14(23):7854-61. PubMed ID: 16908174 [TBL] [Abstract][Full Text] [Related]
14. Design and development of water-soluble curcumin conjugates as potential anticancer agents. Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog. Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273 [TBL] [Abstract][Full Text] [Related]
16. A novel ruthenium(II) arene based intercalator with potent anticancer activity. Ruiz J; Vicente C; de Haro C; Bautista D Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164 [TBL] [Abstract][Full Text] [Related]
17. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs. Duan JX; Jiao H; Kaizerman J; Stanton T; Evans JW; Lan L; Lorente G; Banica M; Jung D; Wang J; Ma H; Li X; Yang Z; Hoffman RM; Ammons WS; Hart CP; Matteucci M J Med Chem; 2008 Apr; 51(8):2412-20. PubMed ID: 18257544 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of pochoxime prodrugs as potent HSP90 inhibitors. Wang C; Barluenga S; Koripelly GK; Fontaine JG; Chen R; Yu JC; Shen X; Chabala JC; Heck JV; Rubenstein A; Winssinger N Bioorg Med Chem Lett; 2009 Jul; 19(14):3836-40. PubMed ID: 19410458 [TBL] [Abstract][Full Text] [Related]
19. Design of anticancer prodrugs for reductive activation. Chen Y; Hu L Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784 [TBL] [Abstract][Full Text] [Related]